Steve Forte - 04 Mar 2025 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role: EVP, CHIEF FINANCIAL OFFICER
Signature: /s/ Steve Forte
Issuer symbol: RPTX
Transactions as of: 04 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 06 Mar 2025, 17:00:06 UTC
Previous filing: 01 Apr 2024
Next filing: 14 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPTX	Common Shares	Award	$0	+14,000	+29%	$0.000000	61,670	04 Mar 2025	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RPTX	Employee Stock Option (right to buy)	Award	$0	+200,000		$0.000000	200,000	04 Mar 2025	Common Shares	200,000	$1.17	Direct	F3
transaction	RPTX	Employee Stock Option (right to buy)	Award	$0	+85,000		$0.000000	85,000	04 Mar 2025	Common Shares	85,000	$1.17	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of March 4, 2026, March 4, 2027 and March 4, 2028, subject to Reporting Person continuing to provide service through each such date.
F2	Includes 895 and 2,000 shares acquired on August 15, 2024 and February 15, 2025, respectively, under the Issuer's employee stock purchase plan.
F3	The option will vest in in full on March 4, 2026, subject to Reporting Person continuing to provide service through such date.
F4	Twenty-five percent (25%) of the shares subject to the option shall vest on March 4, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.